Literature DB >> 25150160

Molecular characterization of calreticulin from Anopheles stephensi midgut cells and functional assay of the recombinant calreticulin with Plasmodium berghei ookinetes.

Nahid Borhani Dizaji1, Hamid Reza Basseri2, Saied Reza Naddaf3, Mansour Heidari4.   

Abstract

Transmission blocking vaccines (TBVs) that target the antigens on the midgut epithelium of Anopheles mosquitoes are among the promising tools for the elimination of the malaria parasite. Characterization and analysis of effective antigens is the first step to design TBVs. Calreticulin (CRT), a lectin-like protein, from Anopheles albimanus midgut, has shown antigenic features, suggesting a promising and novel TBV target. CRT is a highly conserved protein with similar features in vertebrates and invertebrates including anopheline. We cloned the full-length crt gene from malaria vector, Anopheles stephensi (AsCrt) and explored the interaction of recombinant AsCrt protein, expressed in a prokaryotic system (pGEX-6p-1), with surface proteins of Plasmodium berghei ookinetes by immunofluorescence assay. The cellular localization of AsCrt was determined using the baculovirus expression system. Sequence analysis of the whole cDNA of AsCrt revealed that AsCrt contains an ORF of 1221 bp. The amino acid sequence of AsCrt protein obtained in this study showed 64% homology with similar protein in human. The AsCrt shares the most common features of CRTs from other species. This gene encodes a 406 amino-acid protein with a molecular mass of 46 kDa, which contains a predicted 16 amino-acid signal peptides, conserved cysteine residues, a proline-rich region, and highly acidic C-terminal domain with endoplasmic reticulum retrieval sequence HDEL. The production of GST-AsCrt recombinant protein was confirmed by Western blot analysis using an antibody against the GST protein. The FITC-labeled GST-AsCrt exhibited a significant interaction with P. berghei ookinete surface proteins. Purified recombinant GST-AsCrt, labeled with FITC, displayed specific binding to the surface of P. berghei ookinetes in comparison with control. Moreover, the expression of AsCrt in baculovirus expression system indicated that AsCrt was localized on the surface of Sf9 cells. Our results suggest that AsCrt could be utilized as a potential target for future studies in TBV area for malaria control.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anopheles stephensi; Calreticulin; Interaction assay; Localization; Molecular analysis; Plasmodium berghei; Protein characterization; TBV

Mesh:

Substances:

Year:  2014        PMID: 25150160     DOI: 10.1016/j.gene.2014.08.036

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Overexpression of a Triticum aestivum Calreticulin gene (TaCRT1) Improves Salinity Tolerance in Tobacco.

Authors:  Yang Xiang; Yun Hai Lu; Min Song; Yun Wang; Wenqi Xu; Lintao Wu; Hancheng Wang; Zhengqiang Ma
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

2.  Proteome-wide analysis of Anopheles culicifacies mosquito midgut: new insights into the mechanism of refractoriness.

Authors:  Sonam Vijay; Ritu Rawal; Kavita Kadian; Jagbir Singh; Tridibesh Adak; Arun Sharma
Journal:  BMC Genomics       Date:  2018-05-08       Impact factor: 3.969

3.  Experimental Study on Plasmodium berghei, Anopheles Stephensi, and BALB/c Mouse System: Implications for Malaria Transmission Blocking Assays.

Authors:  Hossein Dehghan; Mohammad Ali Oshaghi; Seyed Hassan Mosa-Kazemi; Mohammad Reza Abai; Fatemeh Rafie; Mehdi Nateghpour; Habib Mohammadzadeh; Leila Farivar; Mulood Mohammadi Bavani
Journal:  Iran J Parasitol       Date:  2018 Oct-Dec       Impact factor: 1.012

4.  Extraction of Peptidoglycan from L. paracasei subp. Paracasei X12 and Its Preliminary Mechanisms of Inducing Immunogenic Cell Death in HT-29 Cells.

Authors:  Pei-Jun Tian; Bao-Long Li; Yu-Juan Shan; Jin-Na Zhang; Jing-Yu Chen; Min Yu; Lan-Wei Zhang
Journal:  Int J Mol Sci       Date:  2015-08-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.